HOME >> MEDICINE >> NEWS
GroPep news: Key psoriasis patent granted in Japan and new asthma patent filed for GroPep drug

GroPep Limited announced today the granting in Japan of a key patent covering the active ingredient of its developmental psoriasis drug, PP0102. The world market for psoriasis drugs is more than US$1 billion annually.

The patent news is significant because Japan is a major pharmaceutical market and grant of the patent provides the Company with a patent monopoly until January 16, 2016, with the potential to extend this term by an additional 5 years.

GroPep's Vice President of Commercial Operations, Mr Gregory Moss-Smith, said that with the equivalent patents already granted in the USA and Europe, the Japanese grant completes coverage of the most valuable potential markets.

Exclusive, worldwide rights to the patent were obtained by GroPep in 2002 through a licence from the Northern Sydney and Central Coast Area Health Service (NSCCH). The patent (Japanese Patent No. 3,665,342 - "Novel Peptide") is based on research conducted at the Royal North Shore Hospital by Professor Nick Manolios.

As previously reported by the Company, the PP0102 active ingredient has potential application in other autoimmune diseases, including asthma.

On 27th May 2005, GroPep filed a new International Patent Application on the use of the active ingredient for the treatment of asthma. The application is based on research conducted by scientists at the University of Mainz, Germany and confirmed in studies conducted independently in the United Kingdom. Mr Moss-Smith said that the Company is currently evaluating the commercial merit of developing an asthma treatment.


'"/>

Contact: Mr Tony Mitchell
investorrelations@gropep.com.au
61-8-8354-7700
Research Australia
2-Jun-2005


Page: 1

Related medicine news :

1. GroPep awarded key patent for infertility treatment in Europe
2. GroPep starts Phase 1 infertility trial
3. GroPep completes final milestone of the path malaria vaccine initiative
4. GroPep to pursue promising asthma drug following preclinical study results
5. GroPep licenses technology to TGR BioSciences
6. National Academies news: Polio antivirals should be developed
7. Institute of Medicine news: Report on health care performance
8. Institute of Medicine news: Report on mental illnesses and drug addictions
9. National Academies news: Coeur dAlene Superfund site
10. SCAI news: Drug-eluting stents prove mettle in heart attack patients
11. Institute of Medicine news: Changes needed in WIC program

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/19/2019)... ... ... A July 26 article on Reader’s Digest discusses how at least ... day. The acknowledges that, with dogs not always cooperating with being brushed, many owners ... least twice a week is likely enough to keep canines healthy. The article does ...
(Date:8/19/2019)... ... 18, 2019 , ... More Labs ( http://www.morelabs.com ), the ... SKUs to its line of functional offerings. Aqua+ is an oral rehydration solution ... Aqua+ from other rehydration solutions is the added benefits. On top of electrolytes, ...
(Date:8/17/2019)... ... August 17, 2019 , ... ... America’s Fastest-Growing Private Companies—the Inc. 5000 , For the 2nd Year In a ... Revenue Growth of 192% Percent , Inc. magazine today revealed that YellowTelescope LLC ...
(Date:8/16/2019)... ... August 16, 2019 , ... Cannabinoid Biosciences ... non-pharmaceutical cannabidiol (CBD) products across the CBD market in the United States in ... campaign to raise $50 million on September 9, 2019. , Established on May ...
(Date:8/16/2019)... ... August 16, 2019 , ... The employees ... children’s aircraft to Ronald McDonald House Charities in New Hyde Park, Long Island, ... medical treatments and their family members a comfortable and fun way to watch ...
Breaking Medicine News(10 mins):
(Date:8/17/2019)... ... 17, 2019 , ... Inc. Magazine Unveils Its Annual List ... 2502 on the 2019 Inc. 5000 with Three-Year Revenue Growth of 157% Percent ... firm is No. 2502 on its annual Inc. 5000 list, the most prestigious ...
(Date:8/16/2019)... ... August 16, 2019 , ... SignatureCare Emergency Center has ... Houston, TX including Montrose, Heights, Memorial City, and Bellaire, TX. , The one-day ... Heights, is aimed at helping Houston families get their children caught up on ...
(Date:8/16/2019)... ... August 16, 2019 , ... Quantum Genomics are the creators ... hypertension by acting in the brain to interfere with the renin-angiotensin system. , ... affected by treatment-resistant hypertension, resulting in almost 10 million deaths per year from ...
Breaking Medicine Technology:
Cached News: